跳至主要内容
临床试验/IRCT20160422027520N22
IRCT20160422027520N22招募中2 期

The effects of Tacrolimus on pregnancy outcome in women with recurrent implantation failure (RIF) associated with immunologic factors: clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 41 years(—)
性别
Female

入选标准

  • Disturbed ratio (Th1/Th2)
  • Patients who have experienced at least 3 consecutive implantation failures will be included in our study.
  • Patients who do not have any type of immunotherapy in their medical history will be included in the study.

排除标准

  • Patients under 18 years old and over 41 years oldPatients who themselves or their spouses have abnormal karyotypes or genetic and chromosomal disorders.
  • Patients with coagulation problems.
  • Patients who have an underlying chronic disease and have to take special drugs.
  • Patients whose HIV, HCV or HBV test results are positive.
  • Patients who have a history of asthma and allergy to certain drugs.
  • Patients with intrauterine anomalies.

研究者

相似试验